Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event

Carolyn S.P. Lam(University of Glasgow), Carmine G. De Pasquale, David M. Kaye(Alfred Health), Kaye Carter, Cecilia Currao, Justin A. Ezekowitz(University of Alberta), Carlos Poy, Frank Edelmann(Humboldt-Universität zu Berlin), Burkert Pieske(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Claudio Majul, Adrian F. Hernandez(Duke University), Jens Refsgaard, Florencia Eden, John Amerena(Clinical Trial Investigators), Daniel Agustín Chirino Navarta, Gerardo Zapata, S. McKenzie(Mercyhurst University), Paul W. Armstrong(Canadian VIGOUR Centre), Miguel Hominal, Ignacio MacKinnon, Karen Sliwa(University of Cape Town), V Novas, Edimar Alcides Bocchi(Universidade de São Paulo), Maria Veronica Bianchini, Jesus Cuadrado, Ana Cenci, María Laura Poy, Kevin J. Anstrom(University of North Carolina at Chapel Hill), Cesar Javier Zaidman, Anna Giczewska, Eduardo Perna, Maria Mangini(Institute for Experimental Endocrinology and Oncology), Mariana Perrin, Andrea Alvarez D'Amelio, Kathryn Stibijl, Ezequiel Hector Vottero, Paula Bordoni, Luciana Arias, Sonia A Sassone, Mahesh J. Patel, Rodolfo Andrés Ahuad Guerrero, Christopher M. O’Connor(Inova Health System), Hugo A Luquez, Luis R Cartasegna, Lothar Roessig(Bayer (Germany)), Toni Shanahan, Maria Galarza Salazan
JAMA Cardiology
November 13, 2020
Cited by 84


Related Papers